UNIGE document Scientific Article
previous document  unige:7454  next document
add to browser collection
Title

Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6)

Authors
Opravil, Milos
Ledergerber, Bruno
Furrer, Hansjakob
Imhof, Alexander
Gallant, Serge
Wagels, Thomas
show hidden authors show all authors [1 - 11]
Published in AIDS. 2002, vol. 16, no. 10, p. 1371-1381
Abstract OBJECTIVE: To evaluate the efficacy of early initiation of highly active antiretroviral therapy (HAART), we compared the clinical course of two nested, matched cohorts within the Swiss HIV Cohort Study. METHODS: We selected all asymptomatic patients who started HAART between 1 January 1996 and 31 December 1999 with a CD4 cell count > 350 x 10(6)/l. We then matched them with asymptomatic participants who were seen at around the same time and who remained untreated during the following 12 months. This control group was further matched for age, sex, CD4 cell count, viral load, and HIV risk category, generating 283 pairs of treated versus untreated patients. RESULTS: During observation of median 3.19 versus 2.66 years, CDC stage B/C occurred in 6.4% versus 21.2%, AIDS in 1.8% versus 5.3%, death in 2.1% versus 6.4%, and AIDS or death of 'natural' causes in 2.8% versus 6.7% of the treated versus untreated patients. In multivariable Cox regression analysis, treatment reduced the risk of clinical progression by a factor of four- to five fold. During follow-up, the treated group had significantly higher CD4 counts and lower HIV-1 RNA levels. Intolerance/adverse events led to change or stop of at least one drug in 35% of treated patients. The entire regimen was interrupted at least once by 41% of patients, and 24% had no treatment anymore at the end of follow-up. CONCLUSIONS: The initiation of HAART in asymptomatic patients with CD4 cell count > 350 x 10(6)/l significantly delayed clinical progression. However, the risk of severe clinical events with deferred therapy was low and must be counter balanced against the burden and toxicity of HAART.
Keywords Acquired Immunodeficiency Syndrome/drug therapyAnti-HIV Agents/ therapeutic useAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCohort StudiesDisease ProgressionFemaleHIV Infections/ drug therapy/immunologyHumansMaleProportional Hazards ModelsTreatment OutcomeViral Load
Identifiers
PMID: 12131214
Full text
Structures
Citation
(ISO format)
OPRAVIL, Milos et al. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6). In: AIDS, 2002, vol. 16, n° 10, p. 1371-1381. https://archive-ouverte.unige.ch/unige:7454

131 hits

0 download

Update

Deposited on : 2010-06-21

Export document
Format :
Citation style :